0.645
-0.03 (-3.76%)
Previous Close | 0.670 |
Open | 0.653 |
Volume | 2,114,254 |
Avg. Volume (3M) | 543,755 |
Market Cap | 7,481,163 |
Price / Sales | 0.240 |
Price / Book | 0.420 |
52 Weeks Range | |
Earnings Date | 13 Aug 2025 - 18 Aug 2025 |
Profit Margin | -108.21% |
Operating Margin (TTM) | -96.40% |
Diluted EPS (TTM) | -3.06 |
Quarterly Revenue Growth (YOY) | -4.70% |
Total Debt/Equity (MRQ) | 3.35% |
Current Ratio (MRQ) | 2.18 |
Operating Cash Flow (TTM) | -19.54 M |
Levered Free Cash Flow (TTM) | -9.87 M |
Return on Assets (TTM) | -27.52% |
Return on Equity (TTM) | -93.11% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Bearish | Bearish |
Medical Devices (Global) | Bearish | Bearish | |
Stock | Lifeward Ltd. | Mixed | Bearish |
AIStockmoo Score
Analyst Consensus | -2.0 |
Insider Activity | NA |
Price Volatility | 0.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | -2.5 |
Average | -0.38 |
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Core |
% Held by Insiders | 3.34% |
% Held by Institutions | 2.58% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |